underlies the measurement of blood pH as an
important part of the efforts to control the quality
of blood products. That is, at the end of storage, the
pH level of the blood in the blood bag may not be
≤ 6.4. In this study, the blood bag sample used
anticoagulant Citrate Phosphate Dextrose Adenine
(CPDA-1) of which the ratio between blood
volume and anticoagulant volume was x: x. During
the 28 day storage, the blood pH was measured on
days 0, 1, 7, 14, 21 and 28 days. According to the
measurement done 6 hours after tapping (day 0),
the blood pH was
7.30. On the 1st day, the pH level was observed to
decrease by 0.1 to 7.20 and this remained stable
until the 7th day. However, there was another pH
decline on the 14th day by 0.2 to 7.10. On the last
storage day, i.e. the 28
th
day, there was a quite
significant decrease in the pH, i.e. 6.90. Some of
the factors that might have an important effect on
lowering the pH level during storage are:
1.
The use of anticoagulant CPDA-1 which
contains an acid compound
2.
Respiration by blood cells produces carbon
dioxide. In the body, carbon dioxide is
processed by the lungs, but the blood bag
does not have such function, causing
respiratory acidosis which disrupts blood
buffer retention, thus lowering pH level.
3.
Cellular metabolism which continues to take
place during storage, decreasing the ATP
level and glucose in the blood. One of the
products of cellular metabolism is lactic acid.
Lactic acid accumulation could also lower
the pH level.
4 CONCLUSIONS
Based on the results of this study, in general, the
pH value and the number of erythrocytes,
leukocytes, and platelets decrease during the 28-
day storage. In fact, the number of erythrocytes and
pH values are still within the normal range, while
the number of leukocytes and platelets is below the
normal range. Therefore, it is important to process
blood into particular blood components to
guarantee and provide the quality of the
components needed.
REFERENCES
AABB. 2017. Circular of information for the use of Human
Blood and Blood Components. Armed Services Blood
Program
Ampofo, W., Trebi, N. N., Ansah, J., Abe, K.
2002.Prevalence of blood-borne infectious diseases in
blood donors in Ghana. J. Clin Microbiol, 40, 3523–
3525.
Avery DM, Avery KT. 2011. Blood component therapy.
Am J Clin Med, 7:57-9.
Booth, C and Allard, S. 2017. Blood transfusion. Medicine,
45(4): 244-250.
Dellinger, E. P., Anaya, D. A., 2004. Infectious and
immunologic consequences of blood transfusion. Crit.
Care, 8, 18–23.
Eldin KW, dan Teruya J. 2012. Blood components for
hemostasis. Lab Med, 43; 237-44.
Getz TM. 2019. Physiology of cold platelets. Transfus
Apher Sci, 58(1): 12-15.
Hall JE, Guyton and Hall. 2015. Textbook of Medical
Physiology. 13th edition, Saunders
Hughes, J.D., Macdonald, VW, Hess, J.R. 2007.Warm
storage of whole blood for 72 hours. Transfusion,
47(11)
Kementerian Kesehatan Republik Indonesia. 2015.
Peraturan Menteri Kesehatan No.91 Tahun 2015
tentang Standar Pelayanan Transfusi Darah. Jakarta
Kucukakin B, Kocak V, Lykkesfeldt J, Nielsen HJ,
Magnussen K, Rosenberg J, Gogenur I. 2011. Storage-
induced increase in biomarkers of oxidative stress and
inflammation in red blood cell components. Scand J
Clin Lab Invest, 71:299-303.
Kurup, PA., Arun, P., Gayathri, NS., Dhanya, CR., Indu R.
2003. Modified fomulation of CPDA for storage of
whole blood and of SAGM for storage of red blood
cells, to maintain the concentration of 2,3-
diphosphoglycerate.Vox Sanguinis, 85(4):253-61
Riswanto, 2013. Pemeriksaan Laboratorium Hematologi.
Alfamedia & Kanal Medika. Yogyakarta
Roenhorst, H. W., Kallenberg, G. M., The, T. H., 1988. The
cellular immune response to cell-associated and cell-
free cytomegalovirus (CMV) antigens after primary
CMV-infection in non-immunocompromised hosts:
Development and maintenance of CMV-latency and its
influence on immunocompetence. Clin. Exp. Immunol,
74, 326–332
Seidl, S.,Kuhnl, P.,1987. Transmission of diseases by blood
transfusion. World J. Surg. 11, 30–35
Seghatchian, J. Hervig T., Putter JS. 2011. Effect of
pathogen inactivation on the storage lesion in red cells
and platelet concentrates. Transfus Apher Sci, 45:75- 94
Slichter, S. J., Fitzpatrick, L., Osborne, B., Christoffel,
T.,Gettinge, I., Pellham, E. Bailey, L., Jones, MK.,
Herzig, MC., Cap, A. 2019. Platelets stored in whole
blood at 4°C: in vivo posttransfusion recoveries and
survivals and in vitro hemostatic function. Transfusion,
00:1-9
Vamvakas, E. C., 2006. The case against universal white
blood cell reduction. ISBT Sci. Series, 1, 64–72.